نتائج البحث - "Karen Minde Fagerli"

المصدر: Annals of the Rheumatic Diseases
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Lindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, ' Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration ', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418 . https://doi.org/10.1136/annrheumdis-2021-220097Test

مصطلحات موضوعية: Male, Placebo-controlled study, Psoriatic, PLACEBO-CONTROLLED TRIAL, THERAPY, Etanercept, DOUBLE-BLIND, 0302 clinical medicine, Immunology and Allergy, Medicine, 030212 general & internal medicine, skin and connective tissue diseases, Remission Induction, Middle Aged, Tumour necrosis factor inhibitors, Treatment Outcome, arthritis, Antirheumatic Agents, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, Adult, medicine.medical_specialty, Immunology, Psoriatic Arthritis, tumour necrosis factor inhibitors, General Biochemistry, Genetics and Molecular Biology, methotrexate, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Internal medicine, Adalimumab, Humans, 030203 arthritis & rheumatology, business.industry, Arthritis, Arthritis, Psoriatic, EFFICACY, medicine.disease, Infliximab, Discontinuation, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Tumor Necrosis Factor Inhibitors, psoriatic, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022e520d9e5e31bc0cc0baf6321a0476Test
http://europepmc.org/articles/PMC8522446Test

4

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation

المؤلفون: Monica Hernandez Alava, Allan Wailoo, Georgios Chrysanthou, Filipe Barcelos, Floris A van Gaalen, Helena Santos, Karen Minde Fagerli, Laura Gago, Maria Margarida Cunha, Marleen van de Sande, Maura C Couto, Miguel Bernardes, Roberta Ramonda, Sofia Exarchou, Pedro D Carvalho, Desirée van der Heijde, Pedro M Machado

المساهمون: Comprehensive Health Research Centre (CHRC) - pólo NMS, Centro de Estudos de Doenças Crónicas (CEDOC), NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM), Clinical Immunology and Rheumatology, AII - Inflammatory diseases

المصدر: RMD Open, 8(1). BMJ PUBLISHING GROUP
RMD open, 8(1):e001955. BMJ Publishing Group

مصطلحات موضوعية: Cost-Benefit Analysis, Immunology, Reproducibility of Results, spondylitis, economics, Severity of Illness Index, ankylosing, patient reported outcome measures, Rheumatology, Surveys and Questionnaires, Quality of Life, Humans, Immunology and Allergy, Prospective Studies, Axial Spondyloarthritis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ca9e5918fef7d07fdf1d5233fbcc3fTest
http://hdl.handle.net/1887/3330005Test

5

One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

المصدر: The Journal of Rheumatology. :jrheum.220459

مصطلحات موضوعية: Rheumatology, Immunology, Immunology and Allergy

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::64aca21f6e7bbb4afe1a75751d2dbe51Test
https://doi.org/10.3899/jrheum.220459Test

6

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

المساهمون: Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, AMS - Tissue Function & Regeneration

المصدر: Rheumatology, 61, 12, pp. 4741-4751
Nissen, M, Delcoigne, B, Di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology, vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174Test
Nissen, M, Delcoigne, B N, di Giuseppe, D, Jacobsson, L, Hetland, M L, Ciurea, A, Nekvindova, L, Iannone, F, Akkoc, N, Sokka-Isler, T, Fagerli, K M, Santos, M J, Codreanu, C, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, van der Horst-Bruinsma, I, Loft, A G, Möller, B, Mann, H, Conti, F, Yildirim Cetin, G, Relas, H, Michelsen, B, Avila Ribeiro, P, Ionescu, R, Sanchez-Piedra, C, Tomsic, M, Geirsson, Á J N, Askling, J, Glintborg, B & Lindström, U 2022, ' The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis ', Rheumatology (Oxford, England), vol. 61, no. 12, pp. 4741-4751 . https://doi.org/10.1093/rheumatology/keac174Test
Rheumatology (Oxford, England), 61(12), 4741-4751. Oxford University Press
Nissen, Michael; Delcoigne, Bénédicte; Di Giuseppe, Daniela; Jacobsson, Lennart; Hetland, Merete Lund; Ciurea, Adrian; Nekvindova, Lucie; Iannone, Florenzo; Akkoc, Nurullah; Sokka-Isler, Tuulikki; Fagerli, Karen Minde; Santos, Maria Jose; Codreanu, Catalin; Pombo-Suarez, Manuel; Rotar, Ziga; Gudbjornsson, Bjorn; van der Horst-Bruinsma, Irene; Loft, Anne Gitte; Möller, Burkhard; Mann, Herman; ... (2022). The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis. Rheumatology, 61(12), pp. 4741-4751. Oxford University Press 10.1093/rheumatology/keac174 <http://dx.doi.org/10.1093/rheumatology/keac174Test>
Rheumatology, 61, 4741-4751